Otodolor® eardrops/Otodolor® forte eardrops: a topical treatment of otitis externa

Safety and efficacy of the homeopathic remedies Otodolor® eardrops/Otodolor® forte eardrops for topical treatment of otitis externa: a non-interventional trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN66288854

Enrollment

196

Registered

2009-10-22

Start date

2008-09-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Otitis externa Ear, Nose and Throat Otitis externa

Interventions

Otodolor® eardrops (every 2 - 4 hours, 3 - 5 drops/ear) or Otodolor® forte eardrops (every 2 - 4 hours, 3 - 5 drops/ear) for topical treatment of otitis externa over a 2-week period.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with acute or chronic otitis externa presenting to ENT doctors or paediatricians 2. Children aged 6 years onwards and adults (either sex) for Otodolor® eardrops 3. Children aged 12 years onwards and adults (either sex) for Otodolor® forte eardrops

Exclusion criteria

Exclusion criteria: 1. Patients under the age of 6 years 2. A known or suspected perforation of the eardrum

Design outcomes

Primary

Measure	Time frame
1. The reduction of subjective and objective complaints like redness, swelling, eczematous affections, secretion, ear pain and itching 2. The reduction of other otitis externa medications under therapy	—

Secondary

Measure	Time frame
Safety assessment (adverse drug reactions [ADRs])	—

Countries

Austria

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026